Performance of Activities Sample Clauses

Performance of Activities. The Nurse Representative shall notify her/his immediate supervisor prior to performing permitted Nurse Representative duties on work time. If, in the supervisor’s discretion, the permitted activity would interfere with the work of the Nurse Representative or other employees, the Nurse Representative will arrange with the responsible supervisor(s) for a mutually satisfactory time to perform the requested activity.
Performance of Activities. Data Recipient may use and disclose the Limited Data Set only (1) in the performance of the research activities (the “Activities”) as detailed in Attachment B to this Agreement, or (2) subject to the provisions of Section 3.d, as otherwise required by law.
Performance of Activities. In the event of a termination, (a) Investigator will immediately stop enrolling subjects into the Study and cease conducting Study procedures and treatment with the Study Drug on subjects already entered into the Study, to the extent medically advisable, and (b) Institution and/or Investigator will (i) furnish to Sponsor all Study Data and all CRFs, completed or partially complete, as of the effective date of termination, and (ii) return to Sponsor all Materials (defined below) that were furnished to Institution or Investigator, in accordance with Sponsor’s instruction, except for records or samples which the Institution and/or Investigator is required by law to retain. Within thirty (30) days of termination of this Agreement or completion of the Study (whichever comes first), (b) Provádění aktivit. V případě ukončení (a) Zkoušející okamžitě zastaví nábor subjektů do Studie a ukončí provádění studijních postupů a léčby Hodnoceným přípravkem u subjektů, které již byly zařazeny do Studie v míře z lékařského hlediska vhodné, a (b) Poskytovatel zdravotních služeb a/nebo Zkoušející (i) poskytne Zadavateli všechna Studijní data a všechny CRF, které budou vyplněny nebo částečně vyplněny, od data platnosti ukončení, a (ii) vrátí Zadavateli všechny Materiály (definované níže), které byly dodány Poskytovateli zdravotních služeb nebo Zkoušejícímu, v souladu s instrukcemi Zadavatele, kromě záznamů nebo vzorků, které musí Poskytovatel zdravotních služeb a/nebo Zkoušející uchovat podle zákona. Během třiceti (30) dnů od ukončení této Smlouvy nebo dokončení Studie (podle toho, co nastane jako první) předloží Investigator will submit final written reports to Sponsor, which reports shall be consistent with industry standards and any criteria or requirements therefore specified in the Protocol. After termination of this Agreement or suspension of the Study at the Institution for any reason, all Parties shall continue activities under this Agreement solely as deemed necessary by mutual written agreement of the Parties based on reasonable medical judgment to protect the health of subjects participating in the Study. This Section 2.5 survives termination of this Agreement. Zkoušející Zadavateli závěrečné písemné zprávy, které budou odpovídat oborovým standardům a všem kritériím nebo požadavkům, které jsou za tímto účelem specifikovány v Protokolu. Po ukončení této Smlouvy nebo po zastavení Studie ve Zdravotnickém zařízení z jakéhokoli důvodu budou všechny Smluvní strany pokračo...
Performance of Activities. Data User may use and disclose the Limited Data Set only in connection with the performance of the [research activities] [public health activities] [health care operations] provided in Exhibit A, attached to this Agreement (the “Activities”). Data User shall limit the use or receipt of the Limited Data Set to the following individuals or classes of individuals who need the Limited Data Set for the performance of the Activities: [ ].
Performance of Activities. (a) Performance of the Activities shall be coordinated with a representative of Owner to minimize unreasonable interference with normal operation of the Premises. All Activities at the Premises shall be performed during normal business hours or at such other times and on such days of the week as Owner shall determine in its reasonable discretion and shall be performed in a manner that will not have any material adverse effect on Owner, or any other person or entity granted rights of use and occupancy through Owner, their respective agents, employees or invitees, or all of them. (b) Upon completion of the Activities, Entrant shall, at its sole cost and expense, promptly remove and dispose of off of the Premises, in accordance with all Environmental Laws, all equipment, material, soil, water and debris which exists on the Premises as a result of Entrant’s collection of samples from the Premises. (c) Entrant shall use commercially reasonable efforts to cause its environmental consultant, to reasonably cooperate and coordinate with Owner for the collection of samples of any testing of soils or ground water at the Premises in accordance with Section 6 of this Agreement. (d) All Activities performed at the Premises by Entrant or the Permitted Parties shall, once begun, be completed with reasonable diligence and paid for in full by Entrant, free and clear of all mechanic’s or other liens and encumbrances, and shall be performed in accordance with all applicable statutes, ordinances, rules, regulations, orders and requirements of any Governmental Authority, including without limitation, Environmental Laws. All Activities performed by Entrant or the Permitted Parties shall be done in a good and workmanlike manner, and, subject to Section 6 of this Agreement, in such a manner so as not to cause any unreasonable damage to the Premises or unreasonable interference with the use and occupancy of the Premises by Owner, or any other person or entity granted rights of use and occupancy through Owner, or their respective agents, employees or invitees. Entrant shall restore, repair or replace, as the case may be, any damage to the Premises caused by the Activities to substantially the same condition as existed at the time the Activity which caused such damage commenced.
Performance of Activities. Data User may use and disclose the Limited Data Set received from Covered Entity only in connection with the performance of Data User shall limit the use or receipt of the Limited Data Set to the following individuals or classes of individuals who need the Limited Data Set for the performance of the Activities: For HIV-related information, Data User hereby acknowledges and agrees that Covered Entity has notified Data User that it is required to comply with the confidentiality, disclosure and re-disclosure requirements of 10 NYCRR Part 63.
Performance of Activities. Data User may use and disclose the Limited Data Set received from Covered Entity only in connection with the performance of the activities described on the “Request to Access Health Information by Use of a Limited Data Set” attached to this Agreement (the “Activities”). Data User shall limit the use or receipt of the Limited Data Set to the individuals or classes of individuals described on the attached “Request to Access Health Information by Use of a Limited Data Set” who need the Limited Data Set for the performance of the Activities.
Performance of Activities. Company shall use Commercially Reasonable Efforts to obtain Regulatory Approval of a Company Product and Foresight shall use Commercially Reasonable Efforts to obtain Regulatory Approval of a Foresight Assay for use as a Companion Diagnostic with a Company Product. Each Party shall use [***] to perform the Activities, including the provision of any in each case, assigned or allocated to it under the Work Plan. Each Party will promptly notify the other, in writing or via discussions during a JSC meeting, if: (a) material delays are likely and outline Party’s proposed plan to remediate such delays if they are within such Party’s reasonable control, or (b) a Party encounters any issue that has (or would reasonably be expected to have) a material impact on any Activities contemplated by the applicable Work Plan. Each Party will comply with Applicable Laws with respect to the conduct of the Activities and production of Deliverables and with any additional specific regulatory framework agreed to in a Work Plan, Quality Agreement or other specific standards set forth in a Work Plan or Quality Agreement. For the avoidance of doubt, each Party will comply with applicable: (x) Good Laboratory Practices, (y) Good Clinical Practices, and (z) regulatory requirements of each jurisdiction contemplated under the Work Plan. With respect to Foresight’s performance of Activities, it shall comply with the minimum security requirements set forth in Exhibit D attached hereto.
Performance of Activities. In the event of a termination, (a) Investigator will immediately stop enrolling subjects into the Study and cease conducting Study procedures and treatment with the Study Drug on subjects already entered into the Study, to the extent medically advisable, and (b) Institution and/or Investigator will (i) furnish to Sponsor all Study Data and all CRFs, completed or partially complete, as of the effective date of termination, and (ii) return to Sponsor all Materials (defined below) that were furnished to Institution or Investigator, in accordance with Sponsor’s instruction, except for records or samples which the Institution and/or Investigator is required by law to retain. Within thirty (30) days of termination of this Agreement or completion of the Study (whichever comes first), Investigator will submit final written reports to Sponsor, which reports shall be consistent with industry standards and any criteria or requirements therefore specified in the Protocol. After termination of this Agreement or suspension of the Study at the Institution for any reason, all Parties shall continue activities under this Agreement solely as deemed necessary by mutual written agreement of the Parties based on reasonable medical judgment to protect the health of subjects participating in the Study. This Section 2.5 survives termination of this Agreement.
Performance of Activities. Data User may use and share findings resulting from analysis of the Limited Data Set received from Covered Entity only in connection with the performance of the evaluation/research activities (“Activities”) described below NCOA requires a high-level overview of the goals, objectives, research designs/approach, measures, and any plans to merge or link NCOA data sources to other data sources (e.g. national health data sources) written in laymen’s terms in the section below. Attach additional information, if needed. An Institutional Review Board (IRB) approval document from the Data User’s institution or other trusted entity is required, if applicable to the Data User’s institution. Please attach a copy.